ArticleCureus2025
Placenta Percreta in the Absence of a Previous Uterine Scar.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Placenta accreta spectrum (PAS) encompasses abnormal placental adherence to the myometrium, ranging from accreta to percreta, and is a major cause of life-threatening hemorrhage. While prior cesarean section and placenta previa are the main risk factors, PAS in the absence of uterine scarring is rare. We report two cases of PAS without prior uterine surgery. The first involved a 42-year-old woman with beta-thalassemia major and a history of cesarean section, who conceived via in vitro fertilization (IVF). She presented at 30 weeks with acute abdominal pain, hypovolemic shock, and fetal demise. Emergency laparotomy revealed posterior uterine rupture and placenta percreta. Despite a hysterectomy and repeated interventions, the patient died due to uncontrolled hemorrhage and coagulopathy. The second case involved a multiparous woman with no surgical history, who presented at 32 weeks with severe bleeding and fetal distress. Intraoperatively, an anterior placenta percreta invading through the uterine serosa was found. A hysterectomy was performed with a favorable maternal outcome. These cases highlight PAS occurrence in women without prior uterine scars, suggesting that additional factors such as beta-thalassemia, chronic hypoxia, oxidative stress, and altered angiogenesis may contribute to abnormal placental invasion. The first case strongly suggests a possible association between beta-thalassemia and PAS. Spontaneous uterine rupture due to unrecognized PAS underscores the need for vigilance even in low-risk women. PAS can occur without classic risk factors and may be linked to systemic conditions such as beta-thalassemia. Early recognition, multidisciplinary management, and timely hysterectomy are crucial to improving maternal outcomes. Further studies are warranted to clarify the role of beta-thalassemia and other non-surgical risk factors in PAS pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.